Physician profile
James Allen Wright
NPI 1386640613
$5,602.50
in general payments reported to CMS, 2019-2025
15 companies · $2,275 in 2025
The $2,275 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $989 · 2023: $983 · 2024: $1,356 · 2025: $2,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,360 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,359.83 |
| Education | $253.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,667.61 | 2022-2025 | |
| Amgen INC. | $1,637.95 | 2022-2025 | Evenity, Enbrel, Prolia |
| Janssen Biotech, INC. | $808.19 | 2024-2025 | Tremfya, Simponi Aria |
| Ucb, INC. | $594.83 | 2022-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $371.70 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $172.69 | 2022-2025 | Saphnelo |
| Radius Health, INC. | $115.59 | 2022-2025 | Tymlos |
| Genentech USA, INC. | $54.82 | 2024-2025 | Actemra, Gazyva |
| Mallinckrodt Hospital Products INC. | $52.46 | 2022-2023 | Acthar |
| Actelion Pharmaceuticals US, INC. | $38.40 | 2023-2024 | Uptravi, Opsumit |
| Sandoz INC. | $23.43 | 2025 | Jubbonti |
| Pfizer INC. | $18.91 | 2022 | |
| Genzyme Corporation | $16.44 | 2024 | |
| Lilly USA, LLC | $15.33 | 2022 | |
| Horizon Therapeutics Plc | $14.15 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.